Earnings
Merck and Pfizer Earnings Highlight Pharma’s Split Market Reaction
Merck (MRK) and Pfizer (PFE) reported fourth-quarter results that beat earnings expectations, but below-consensus 2026 guidance weighed on sentiment, producing diverging stock reactions and highlighting ongoing transition risks across big pharma.